CARIS CHROMOSEQ Trademark

Trademark Overview

On Thursday, April 24, 2025, a trademark application was filed for CARIS CHROMOSEQ with the United States Patent and Trademark Office. The USPTO has given the CARIS CHROMOSEQ trademark a serial number of 99153728. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 7, 2025. This trademark is owned by Caris MPI, Inc.. The CARIS CHROMOSEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection ¬and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies

Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies
caris chromoseq

General Information

Serial Number99153728
Word MarkCARIS CHROMOSEQ
Filing DateThursday, April 24, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, October 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection ¬and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies
Goods and ServicesMedical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCaris MPI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Trademark Events

Event DateEvent Description
Thursday, April 24, 2025NEW APPLICATION ENTERED
Thursday, April 24, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, September 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 16, 2025ASSIGNED TO EXAMINER
Tuesday, October 7, 2025NON-FINAL ACTION WRITTEN
Tuesday, October 7, 2025NON-FINAL ACTION E-MAILED
Tuesday, October 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

chromoseq caris medical whole research scientific lymphoma detection patients leukemia other testing